{"id":"lng-ius","safety":{"commonSideEffects":[{"rate":"20-30","effect":"Irregular bleeding or amenorrhea"},{"rate":"5-10","effect":"Abdominal/pelvic pain"},{"rate":"5","effect":"Headache"},{"rate":"5","effect":"Breast tenderness"},{"rate":"2-5","effect":"Device expulsion"},{"rate":"<1","effect":"Perforation (rare)"}]},"_chembl":{"chemblId":"CHEMBL594631","moleculeType":"Small molecule","molecularWeight":"599.61"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The device releases levonorgestrel (a synthetic progestin) in small amounts over several years, which thickens cervical mucus to prevent sperm penetration, alters the endometrium to prevent implantation, and may suppress ovulation in some cycles. This localized hormonal delivery provides contraceptive efficacy comparable to sterilization while maintaining reversibility.","oneSentence":"LNG-IUS is a levonorgestrel-releasing intrauterine system that provides long-acting reversible contraception by releasing a synthetic progestin directly into the uterus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:52:39.369Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception"},{"name":"Heavy menstrual bleeding (off-label/secondary indication)"}]},"trialDetails":[{"nctId":"NCT05172999","phase":"PHASE2, PHASE3","title":"Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia","status":"COMPLETED","sponsor":"Fudan University","startDate":"2022-01-08","conditions":"Atypical Endometrial Hyperplasia, Obesity, Fertility Issues","enrollment":30},{"nctId":"NCT07382583","phase":"","title":"Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-02-12","conditions":"Levonorgestrel, Intrauterine Systems, Prevention","enrollment":270},{"nctId":"NCT07229209","phase":"NA","title":"Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Benha University","startDate":"2025-02-05","conditions":"Abnormal Uterine Bleeding, Cesarean Section Complications, Uterine Scar","enrollment":166},{"nctId":"NCT02397083","phase":"PHASE2","title":"Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-09-23","conditions":"Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma","enrollment":102},{"nctId":"NCT06552598","phase":"PHASE1","title":"The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2024-04-01","conditions":"Cervical Cancer, Gynecologic Malignancies, Endometrial Cancer","enrollment":97},{"nctId":"NCT00788671","phase":"PHASE2","title":"Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2008-11-03","conditions":"Atypical Endometrial Hyperplasia, Stage I Uterine Corpus Cancer AJCC v7, Stage IA Uterine Corpus Cancer AJCC v7","enrollment":69},{"nctId":"NCT05316493","phase":"PHASE2, PHASE3","title":"Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia","status":"RECRUITING","sponsor":"Xiaojun Chen","startDate":"2022-06-13","conditions":"Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity","enrollment":172},{"nctId":"NCT01088178","phase":"NA","title":"Levonorgestrel-Intrauterine System (LNG-IUS) Insertion in the Postpartum Period","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2009-11","conditions":"Contraception","enrollment":""},{"nctId":"NCT01161095","phase":"NA","title":"A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum Period","status":"WITHDRAWN","sponsor":"United States Naval Medical Center, Portsmouth","startDate":"2010-07-01","conditions":"Contraception, Postpartum Period","enrollment":""},{"nctId":"NCT06073184","phase":"PHASE2","title":"Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-08","conditions":"Endometrial Cancer, Atypical Hyperplasia","enrollment":71},{"nctId":"NCT04457076","phase":"PHASE3","title":"Evaluation of the Efficacy, Safety, and Tolerability of LevoCept","status":"NOT_YET_RECRUITING","sponsor":"Sebela Women's Health Inc.","startDate":"2026-06-01","conditions":"Contraception, Women at Risk for Pregnancy","enrollment":1525},{"nctId":"NCT05233956","phase":"NA","title":"Levonorgestrel Intrauterine System Effects on Hemoglobin and Serum Ferritin Among Anemic Women in Kenya","status":"RECRUITING","sponsor":"FHI 360","startDate":"2023-10-23","conditions":"Anemia","enrollment":600},{"nctId":"NCT03708809","phase":"NA","title":"Immediate Versus Delayed Initiation of Intrauterine System","status":"WITHDRAWN","sponsor":"Sheba Medical Center","startDate":"2023-12-01","conditions":"Contraception","enrollment":""},{"nctId":"NCT06620939","phase":"NA","title":"The Effect of Levonorgestrel Intrauterine System in Preventing Endometrial Polyps Recurrence","status":"NOT_YET_RECRUITING","sponsor":"Zhang Jian","startDate":"2024-12-01","conditions":"Endometrial Polyp","enrollment":558},{"nctId":"NCT03241888","phase":"PHASE2, PHASE3","title":"Megestrol Acetate Plus LNG-IUS in Young Women With Endometrial Atypical Hyperplasia","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-07-04","conditions":"Atypical Endometrial Hyperplasia","enrollment":180},{"nctId":"NCT06581679","phase":"NA","title":"Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2023-12-15","conditions":"Adenomyosis","enrollment":184},{"nctId":"NCT06577168","phase":"","title":"Menstrual Pattern Within Six Months of Levonogestrel IUS Insertion","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-12-01","conditions":"Contraception","enrollment":300},{"nctId":"NCT00995150","phase":"PHASE3","title":"A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception","status":"TERMINATED","sponsor":"Medicines360","startDate":"2009-11","conditions":"Contraception","enrollment":1910},{"nctId":"NCT06468215","phase":"NA","title":"Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-07","conditions":"Carcinoma, Endometrioid, Fertility Preservation","enrollment":16},{"nctId":"NCT01721798","phase":"NA","title":"Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women","status":"COMPLETED","sponsor":"FHI 360","startDate":"2013-11-10","conditions":"HIV","enrollment":199},{"nctId":"NCT03493295","phase":"","title":"Non-interventional, Real Life Study on Satisfaction With LNG-IUS in Spanish Young Women (18-30 Years Old) With Different Parity Status and Menstrual Bleeding Pattern","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-04-25","conditions":"Contraception","enrollment":587},{"nctId":"NCT04814927","phase":"PHASE4","title":"Impact of Contraceptives on Cervico-Vaginal Mucosa","status":"COMPLETED","sponsor":"Eastern Virginia Medical School","startDate":"2021-03-01","conditions":"Mucosal Inflammation, Contraceptive; Complications, Intrauterine","enrollment":112},{"nctId":"NCT05986344","phase":"","title":"Uterine Artery Doppler and Menstrual Changes After Insertion Intrauterine Contraceptive Device","status":"UNKNOWN","sponsor":"Beni-Suef University","startDate":"2023-08-30","conditions":"Intrauterine Contraceptive Device Complication","enrollment":165},{"nctId":"NCT02799641","phase":"NA","title":"Effect of Multimodal Analgesia on Pain With Insertion of Levonorgestrel-releasing IUD","status":"COMPLETED","sponsor":"TriHealth Inc.","startDate":"2016-07","conditions":"Contraception","enrollment":61},{"nctId":"NCT04897217","phase":"PHASE3","title":"Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","startDate":"2023-06-30","conditions":"Endometrial Hyperplasia","enrollment":""},{"nctId":"NCT03074045","phase":"PHASE3","title":"LCS16 vs. COC User Satisfaction and Tolerability Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-03-13","conditions":"Contraception","enrollment":145},{"nctId":"NCT04785950","phase":"","title":"The Aim of This Study is to Estimate the Discontinuation Rate of Low-dose Levonorgestrel-releasing Intrauterine System Due to Self-reported Unacceptable Menstrual Bleeding Pattern in Spanish Women Who Are Using it for the First Time How Intrauterine System for Long Acting Contraception","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-02-21","conditions":"Hormonal Intrauterine Contraception","enrollment":316},{"nctId":"NCT00635362","phase":"NA","title":"Postplacental Insertion of Levonorgestrel-releasing Intrauterine System (LNG-IUS) After Cesarean vs. Interval Insertion","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2007-05","conditions":"Healthy","enrollment":42},{"nctId":"NCT00653159","phase":"PHASE4","title":"Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2007-07","conditions":"Contraception","enrollment":23},{"nctId":"NCT04385667","phase":"PHASE2, PHASE3","title":"LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Zagazig University","startDate":"2020-05-20","conditions":"Atypical Endometrial Hyperplasia","enrollment":143},{"nctId":"NCT04663568","phase":"NA","title":"Levonorgestrel-releasing Intrauterine System and Tubal Ligation","status":"TERMINATED","sponsor":"Assiut University","startDate":"2020-12-01","conditions":"Tubal Ligation","enrollment":2},{"nctId":"NCT05594186","phase":"NA","title":"Nonsurgical Management of Cesarean Scar Niche Related Abnormal Uterine Bleeding","status":"COMPLETED","sponsor":"Saudi German Hospital - Madinah","startDate":"2019-03-01","conditions":"Intermenstrual Bleeding","enrollment":158},{"nctId":"NCT05565573","phase":"PHASE2, PHASE3","title":"Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients","status":"UNKNOWN","sponsor":"Hua Li","startDate":"2022-11-01","conditions":"Fertility Sparing","enrollment":148},{"nctId":"NCT05492487","phase":"PHASE2","title":"A Pilot Study on Fertility Conservative Treatment of Atypical Endometrial Hyperplasia in Singapore","status":"UNKNOWN","sponsor":"KK Women's and Children's Hospital","startDate":"2020-01-03","conditions":"Endometrial Hyperplasia, Fertility Issues, Disease Regression","enrollment":60},{"nctId":"NCT04500028","phase":"PHASE4","title":"Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-08-01","conditions":"IUCD Complication","enrollment":220},{"nctId":"NCT02985541","phase":"PHASE3","title":"Mirena Extension Trial","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-12-22","conditions":"Contraception","enrollment":364},{"nctId":"NCT05343546","phase":"NA","title":"Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2022-06","conditions":"Incomplete Abortion, Intrauterine Contraception, Misoprostol","enrollment":2076},{"nctId":"NCT02882191","phase":"PHASE2","title":"Evaluation of the Efficacy and Safety of LevoCept","status":"COMPLETED","sponsor":"Sebela Women's Health Inc.","startDate":"2016-11","conditions":"Contraception","enrollment":279},{"nctId":"NCT05152667","phase":"","title":"Ambispective Study to Assess the Effect of Pretreatment With a Levonorgestrel-Releasing Intrauterine System Versus Oral Progestin","status":"UNKNOWN","sponsor":"Wael Elbanna Clinic","startDate":"2021-11-27","conditions":"Adenomyosis, IVF","enrollment":354},{"nctId":"NCT03317795","phase":"PHASE4","title":"Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids","status":"COMPLETED","sponsor":"Shannon K. Laughlin-Tommaso","startDate":"2017-11-14","conditions":"Heavy Menstrual Bleeding, Menorrhagia, Uterine Fibroids","enrollment":18},{"nctId":"NCT03463252","phase":"PHASE2, PHASE3","title":"Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC","status":"RECRUITING","sponsor":"West China Second University Hospital","startDate":"2018-04-01","conditions":"Endometrial Cancer, Atypical Endometrial Hyperplasia","enrollment":224},{"nctId":"NCT03182140","phase":"","title":"KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-07-06","conditions":"Contraception","enrollment":1134},{"nctId":"NCT02556411","phase":"NA","title":"Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)","status":"UNKNOWN","sponsor":"University of Cagliari","startDate":"2021-06-01","conditions":"Adenomyosis, Chronic Pelvic Pain","enrollment":50},{"nctId":"NCT03428854","phase":"","title":"Adenomyosis: Genomic Mechanisms and Biological Response","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2020-12-01","conditions":"Adenomyosis, Abnormal Uterine Bleeding","enrollment":""},{"nctId":"NCT03992937","phase":"NA","title":"Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia","status":"COMPLETED","sponsor":"Kocaeli University","startDate":"2019-06-20","conditions":"Endometrial Hyperplasia Without Atypia","enrollment":132},{"nctId":"NCT03241914","phase":"PHASE2, PHASE3","title":"Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer","status":"COMPLETED","sponsor":"Fudan University","startDate":"2017-07-04","conditions":"Endometrial Neoplasm Malignant Stage I","enrollment":64},{"nctId":"NCT04517890","phase":"NA","title":"Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":200},{"nctId":"NCT01805817","phase":"PHASE4","title":"Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality","status":"WITHDRAWN","sponsor":"Istanbul Training and Research Hospital","startDate":"2012-12","conditions":"Contraceptive Methods Comparison","enrollment":""},{"nctId":"NCT04045548","phase":"PHASE4","title":"Vaginal Dinoprostone Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System in Women With no Previous Vaginal Delivery","status":"COMPLETED","sponsor":"Cairo University","startDate":"2019-08-10","conditions":"Intrauterine Device","enrollment":200},{"nctId":"NCT03562624","phase":"PHASE2","title":"A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-06-22","conditions":"Contraception","enrollment":177},{"nctId":"NCT03111342","phase":"PHASE4","title":"Intracervical Anesthesia and Pain Associated With Intrauterine Contraceptive Insertion","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2017-06-01","conditions":"Pain, Acute, Anesthesia, Local, IUD Insertion Complication","enrollment":300},{"nctId":"NCT02067663","phase":"","title":"Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2014-04","conditions":"Contraception","enrollment":123},{"nctId":"NCT02824224","phase":"PHASE4","title":"Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2016-09-06","conditions":"Menorrhagia, Metrorrhagia, Medicated Intrauterine Devices","enrollment":42},{"nctId":"NCT02752282","phase":"NA","title":"Anticipatory Counseling on LNG-IUS Continuation, Utilization and Satisfaction","status":"UNKNOWN","sponsor":"University of Washington","startDate":"2016-03","conditions":"Vaginal Bleeding, Uterine Cramping","enrollment":178},{"nctId":"NCT03301480","phase":"","title":"Contraceptive/HIV Affecting Risk in Adolescents","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2017-07-31","conditions":"Contraception, Hiv","enrollment":120},{"nctId":"NCT03230994","phase":"","title":"Cooperative Adenomyosis Network","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2017-06-30","conditions":"Dysmenorrhea, Metrorrhagia, Infertility, Female","enrollment":5000},{"nctId":"NCT02456584","phase":"PHASE1","title":"Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods","status":"COMPLETED","sponsor":"FHI 360","startDate":"2015-09","conditions":"Contraception","enrollment":42},{"nctId":"NCT01598662","phase":"NA","title":"Safety and Expulsion of Delayed Versus Immediate Postpartum Intrauterine Device Placement","status":"TERMINATED","sponsor":"University of Louisville","startDate":"2009-07","conditions":"Contraception","enrollment":32},{"nctId":"NCT01223521","phase":"NA","title":"Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion.","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2010-09","conditions":"Contraception","enrollment":748},{"nctId":"NCT01685164","phase":"","title":"The Effect of Uterine Size and Posture on Intrauterine Contraception in Nulliparous Women","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2011-01","conditions":"Intrauterine Contraception","enrollment":161},{"nctId":"NCT01240811","phase":"NA","title":"Study of Immune Cell Changes in the Genital Tract 2 Months After Initiation of an IUD for Contraception","status":"COMPLETED","sponsor":"Sharon Achilles","startDate":"2010-11","conditions":"Genital Tract Mucosal Immunity, Genital Tract Microflora","enrollment":42},{"nctId":"NCT01601366","phase":"PHASE2","title":"LNG-IUS for Treatment of Dysmenorrhea","status":"COMPLETED","sponsor":"Omar Mamdouh Shaaban","startDate":"2012-04","conditions":"Adenomyosis","enrollment":62},{"nctId":"NCT01254292","phase":"PHASE3","title":"LCS12 vs Combined Oral Contraceptive (COC) User Satisfaction Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-01-06","conditions":"Contraception","enrollment":567},{"nctId":"NCT01594632","phase":"NA","title":"Safety,Effectiveness and Acceptability of Sino-implant II in DR","status":"COMPLETED","sponsor":"FHI 360","startDate":"2011-01","conditions":"Contraception","enrollment":650},{"nctId":"NCT02121067","phase":"PHASE4","title":"LNG-IUS at 2 Weeks Postpartum","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2014-09","conditions":"Contraception, Malposition of Intrauterine Contraceptive Device","enrollment":50},{"nctId":"NCT02480647","phase":"PHASE4","title":"Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2016-05","conditions":"Endometriosis","enrollment":100},{"nctId":"NCT00997932","phase":"PHASE4","title":"A Pilot Study of Early Postpartum Intrauterine Contraception","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2009-06","conditions":"Unplanned Pregnancy","enrollment":40},{"nctId":"NCT02534688","phase":"PHASE4","title":"Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients","status":"COMPLETED","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2015-06","conditions":"Endometriosis","enrollment":50},{"nctId":"NCT03037944","phase":"EARLY_PHASE1","title":"Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-03-01","conditions":"Adenomyosis","enrollment":32},{"nctId":"NCT00528112","phase":"PHASE3","title":"Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":"Contraception","enrollment":2885},{"nctId":"NCT03027648","phase":"NA","title":"Levonorgestrel-releasing Intrauterine System for the Treatment of Symptomatic Adenomyosis","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2006-12","conditions":"Adenomyosis","enrollment":1100},{"nctId":"NCT02990728","phase":"PHASE2","title":"Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2016-03","conditions":"Endometrial Cancer","enrollment":120},{"nctId":"NCT02894151","phase":"PHASE2","title":"Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2015-04","conditions":"Clinically Diagnosed Endometriotic Patient Was Defined as a Woman Who Has Pelvic Pain and at Least One Evidence of PV or TVS","enrollment":50},{"nctId":"NCT01397097","phase":"PHASE3","title":"LCS12 vs. ENG Subdermal Implant (Nexplanon) Discontinuation Rate Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-09","conditions":"Contraception","enrollment":766},{"nctId":"NCT01931657","phase":"PHASE2","title":"Pretreatment With Mifepristone Prior to Mirena Insertion","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2013-08","conditions":"Women in Need of Long Acting Reversibel Cntraception With the Intrauterine Levonorgestrel Releasing System, Mirena","enrollment":60},{"nctId":"NCT01613131","phase":"NA","title":"Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2012-04","conditions":"Menopausal and Other Perimenopausal Disorders","enrollment":39},{"nctId":"NCT01958684","phase":"","title":"Bleeding Pattern Difference Between Levonorgestrel Intrauterine System (LNG-IUS) and Copper Intrauterine Devices (IUDs) Immediately Inserted After Abortion","status":"COMPLETED","sponsor":"Bayer","startDate":"2013-10","conditions":"Contraception","enrollment":512},{"nctId":"NCT02461862","phase":"","title":"Vital Signs and Pain During Insertion of IUD","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2015-01","conditions":"Contraception, Acute Pain","enrollment":285},{"nctId":"NCT02412072","phase":"","title":"Comparison of Dilatation & Curettage and Endometrial Aspiration Biopsy Accuracy in Patients Treated With Progestin for Endometrial Hyperplasia: A Korean Gynecologic Oncology Group Study","status":"UNKNOWN","sponsor":"Korean Gynecologic Oncology Group","startDate":"2015-04","conditions":"Endometrial Hyperplasia","enrollment":75},{"nctId":"NCT02155166","phase":"NA","title":"Effect of Intracervical on the Pain Associated With the Insertion of the LNG-IUS","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2012-02","conditions":"Pain","enrollment":100},{"nctId":"NCT02158845","phase":"PHASE4","title":"Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2010-02","conditions":"Endometriosis","enrollment":44},{"nctId":"NCT01295294","phase":"PHASE4","title":"Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-03","conditions":"Uterine Hemorrhage","enrollment":187},{"nctId":"NCT01943058","phase":"PHASE2","title":"Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer","status":"WITHDRAWN","sponsor":"University of Southern California","startDate":"2014-03","conditions":"Atypical Endometrial Hyperplasia, Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma","enrollment":""},{"nctId":"NCT01555931","phase":"PHASE4","title":"Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2012-03","conditions":"Postpartum Contraception","enrollment":61},{"nctId":"NCT00884260","phase":"PHASE3","title":"GA Levonorgestrel Intrauterine Contraceptive System (LCS) Phase III Study China","status":"COMPLETED","sponsor":"Bayer","startDate":"2009-04","conditions":"Contraception","enrollment":918},{"nctId":"NCT00874653","phase":"","title":"Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-04","conditions":"Menorrhagia","enrollment":78},{"nctId":"NCT00360490","phase":"PHASE3","title":"Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-07","conditions":"Menorrhagia","enrollment":165},{"nctId":"NCT01392157","phase":"PHASE4","title":"Acceptability and Continuation Rate of Implanon in a Brazilian Public Sector","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2011-06","conditions":"Contraceptive Usage, Bleeding Due to Intrauterine Contraceptive Device","enrollment":300},{"nctId":"NCT00185458","phase":"PHASE3","title":"Assessment of the Transfer of Using Levonorgestrel Intrauterine System (LNG IUS) as a Contraceptive to Using it as Part of Hormone Replacement Therapy (HRT).","status":"COMPLETED","sponsor":"Bayer","startDate":"2000-05","conditions":"Menopause","enrollment":394},{"nctId":"NCT00566644","phase":"PHASE3","title":"Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome","status":"TERMINATED","sponsor":"St George's, University of London","startDate":"2007-07","conditions":"Endometrial Cancer, Hereditary Non-polyposis Colon Cancer (hmsh2, hmlh1, hpms1, hpms2)","enrollment":600},{"nctId":"NCT01234818","phase":"PHASE2","title":"Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006","status":"UNKNOWN","sponsor":"Korean Gynecologic Oncology Group","startDate":"2010-11","conditions":"Endometrial Hyperplasia","enrollment":80},{"nctId":"NCT01695902","phase":"PHASE3","title":"Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding","status":"COMPLETED","sponsor":"Uteron Pharma S.A.","startDate":"2007-12","conditions":"Heavy Menstrual Bleeding","enrollment":280},{"nctId":"NCT01388582","phase":"PHASE4","title":"The Effect of Hormonal Contraceptives on Breast-milk Production and Infant Growth","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2011-04","conditions":"Underweight","enrollment":40},{"nctId":"NCT01594879","phase":"PHASE2","title":"Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer","status":"UNKNOWN","sponsor":"Korean Gynecologic Oncology Group","startDate":"2012-01","conditions":"Endometrial Cancer","enrollment":39},{"nctId":"NCT01537562","phase":"NA","title":"Intrauterine Contraception (IUC) After Medical Abortion","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"2007-02","conditions":"IUC Insertion After Medical Abortion","enrollment":129},{"nctId":"NCT01499602","phase":"NA","title":"Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2009-05","conditions":"Endometrial Hyperplasia","enrollment":120},{"nctId":"NCT01320917","phase":"PHASE4","title":"Levonorgestrel-releasing Intrauterine Device on Obese Women: Effects on Hemostatic and Arterial Function","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2009-02","conditions":"Contraception Desired, Obesity","enrollment":88},{"nctId":"NCT01125488","phase":"PHASE3","title":"Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2008-03","conditions":"Endometriosis","enrollment":80},{"nctId":"NCT00966264","phase":"PHASE3","title":"Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia","status":"COMPLETED","sponsor":"University of Helsinki","startDate":"1994-10","conditions":"Menorrhagia","enrollment":236},{"nctId":"NCT00489463","phase":"NA","title":"IUD Uterine Vascularization and Side Effects","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2004-01","conditions":"Healthy","enrollment":63}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1029,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mirena"],"phase":"marketed","status":"active","brandName":"LNG-IUS","genericName":"LNG-IUS","companyName":"University of Texas Southwestern Medical Center","companyId":"university-of-texas-southwestern-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"LNG-IUS is a levonorgestrel-releasing intrauterine system that provides long-acting reversible contraception by releasing a synthetic progestin directly into the uterus. Used for Contraception, Heavy menstrual bleeding (off-label/secondary indication).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}